High glucose-induced endothelial microparticles increase adhesion molecule expression on endothelial cells

Area of Science:

• Endocrinology
• Vascular Biology
• Cell Biology

Background:

• Hyperglycemia is a known risk factor for accelerated atherosclerotic vascular disease.
• Endothelial microparticles (EMPs) are implicated in vascular dysfunction.
• The specific impact of glucose-induced EMPs on endothelial cell adhesion molecule expression requires elucidation.

Purpose of the Study:

• To investigate the in vitro effects of EMPs derived from high glucose conditions on endothelial cell expression of key adhesion molecules.
• To compare the effects of high glucose-derived EMPs (hgEMPs) versus normoglycemic EMPs (ngEMPs) on endothelial cells.

Main Methods:

• Human umbilical vein endothelial cells (HUVECs) were cultured and exposed to either high (25 mM) or normal (5 mM) glucose media to generate EMPs.
• EMPs were identified and quantified using flow cytometry (CD144+).
• HUVECs were subsequently treated with hgEMPs or ngEMPs, and surface expression of E-selectin, ICAM-1, VCAM-1, and PECAM-1 was assessed via flow cytometry.

Main Results:

• Hyperglycemic-derived EMPs (hgEMPs) significantly upregulated the surface expression of E-selectin, ICAM-1, VCAM-1, and PECAM-1 on endothelial cells compared to normoglycemic EMPs (ngEMPs).
• Specific increases in mean fluorescent intensity (MFI) were observed for all tested adhesion molecules when treated with hgEMPs.
• This suggests a direct role for glucose-modified EMPs in promoting endothelial activation.

Conclusions:

• Glucose-induced EMPs enhance endothelial cell expression of adhesion molecules, including E-selectin, ICAM-1, VCAM-1, and PECAM-1.
• This microparticle-induced cell adhesion molecule expression offers potential mechanistic insights into the heightened risk of atherosclerotic vascular disease in hyperglycemic states.
• Targeting EMPs may represent a novel therapeutic strategy for managing hyperglycemia-associated vascular complications.